The largest database of trusted experimental protocols

9 protocols using anti inkt microbeads

1

Modeling HCV-induced Hepatitis in Humanized Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated using Ficoll-Hypaque density gradient centrifugation from a healthy blood donor with HLA-A24. Eight to ten weeks after HCV inoculation, 4×107 human PBMCs were transplanted into human hepatocyte chimeric mice. To assess the effect of depletion of human type I NKT cells from administered PBMCs on hepatitis formation, Anti-iNKT Micro Beads (Milteny Biotec, CA, USA) were used.
+ Open protocol
+ Expand
2

Activation and Isolation of iNKT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs (4–10 × 108) were cultured in cDMEM at 3 × 106 (link) cells/mL with hCII707-721 (100 μg/mL) in T- 175 cm2 flasks (Nunc/Fischer). After activation with hCII707-721 for 48 hours, total iNKT cells were purified by autoMACS using Anti-iNKT MicroBeads (130-094-842, Miltenyi Biotec). To distinguish the hCII707-721-treated iNKT cells before purification from nontreated iNKT cells, the hCII707-721–treated iNKT cell population is referred to as hCII707-721–reactive iNKT cells.
+ Open protocol
+ Expand
3

Expansion and Purification of iNKT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
iNKT cells were expanded from third-party PBMC with some minor modifications as previously described (Online Supplementary Appendix).13 (link) Culture-expanded iNKT cells were purified with antiiNKT MicroBeads (Miltenyi Biotech, Bergisch Gladbach, Germany). Alternatively, iNKT cells were stained with DAPI (4',6- diamidino-2-phenylindole, Merck, Darmstadt, Germany), anti- CD3, anti-CD4, anti-CD8 antibodies and PBS57-loaded CD1d tetramer allowing for enrichment of iNKT cells and their different subsets by fluorescence-activated cell sorting (FACS).
+ Open protocol
+ Expand
4

Expansion and Phenotypic Validation of iNKT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human CD14+ monocytes and iNKT cells were isolated from fresh PBMC by positive selection using CD14 MicroBeads and anti-iNKT MicroBeads (Miltenyi Biotech, Germany), respectively, according to manufacturer’s instructions. iNKT expansion was performed as described (48 (link)) with modifications. Briefly, iNKT were co-cultured with CD14+ monocytes at 1:1 ratio in RPMI 1640 (Sigma) supplemented with 10% fetal bovine serum (Sigma-Aldrich), 2 mM L-glutamine (Gibco), 10 µg/ml gentamicin (Gibco), and 0.25 µg/ml fungizone (Gibco) in the presence of 20 ng/ml GM-CSF (Peprotech), and 20 ng/ml IL-4 (R&D Systems), and 100 ng/ml αGC (Cayman Chemical). Half of the medium was replaced and 20 U/ml IL-2 (Chiron, Emeryville, USA) was added every day from day 2 to day 21 in order to reach around 1×106 cells. ILT2 expression was evaluated and iNKT cells were phenotypically validated by flow cytometry before the iNKT activation assay. Purity of the iNKT cell population was systematically higher than 90%. The iNKT cells used in the activation assay with DC-10 cells were isolated and maintained in culture with the presence of IL-2 and αGC till the autologous mDC and DC-10 cells were differentiated.
+ Open protocol
+ Expand
5

Generation of PBMC-derived T and iNKT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Healthy donor PBMCs were obtained from the UCLA/CFAR Virology Core Laboratory and were used to generate the PBMC-Tc and PBMC-iNKT cells.
To generate PBMC-Tcon cells, PBMCs were stimulated with CD3/CD28 T-activator beads (ThermoFisher Scientific) and cultured in C10 medium supplemented with human IL-2 (20 ng/mL) for 2–3 weeks, following the manufacturer’s instructions.
To generate PBMC-iNKT cells, PBMCs were enrich for iNKT cells using anti-iNKT microbeads (Miltenyi Biotech) and MACS-sorting, followed by stimulation with donor-matched irradiated αGC-PBMCs at the ratio of 1:1 and cultured in C10 medium supplemented with human recombinnat IL-7 (10 ng/mL) and IL-15 (10 ng/mL) for 2–3 weeks. If necessary, the resulting PBMC-iNKT cells could be further purified using Fluorescence-Activated Cell Sorting (FACS) via human iNKT TCR antibody (Clone 6B11; BD Biosciences) staining.
+ Open protocol
+ Expand
6

Expansion and Isolation of Human iNKT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
iNKT cells derived from PBMCs were expanded over 14-21 days as previously described [35] (link). Culture-expanded human iNKT cells were isolated using anti-iNKT MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany). CD3+ T and NK cells were directly isolated from human PBMCs with CD3 MicroBeads or the NK Cell Isolation Kit (both Miltenyi Biotec, Bergisch Gladbach, Germany). MidiMACS Separator and LS Columns were used according to the manufacturer's instructions (Miltenyi Biotec, Bergisch Gladbach, Germany). Isolated T and NK cells were maintained in RPMI 1640 GlutaMAX Supplement Media (Gibco, Grand Island, USA) containing 10% FCS (Gibco, Grand Island, USA) and 100 IU/ml Penicillin/Streptomycin (Lonza, Basel, Switzerland).
+ Open protocol
+ Expand
7

Enrichment and Sorting of iNKT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
iNKT cells represent a very rare population of T cells, being present at a frequency ranging between 0.01 and 1% (ref. 15 (link)). First, we performed magnetic separation using anti-iNKT microbeads (Miltenyi Biotec) followed by staining of the labelled cells. A total of 50 million frozen PBMC was used as starting material. After centrifugation, the cells were resuspended in 400 μl of cold buffer solution (PBS, pH 7.2, 0.5% BSA, 2 mM EDTA) and 100 μl anti-iNKT microbeads were added. Samples were incubated for 15 min in the fridge. At the end of the incubation time, 50 μl of Anti-iNKT-PE antibody (Miltenyi Biotec, Clone 6B11, Catalogue Number 130–098–128) were used for the staining and the cells were kept in the fridge for 5 min. After a washing step, magnetic separation using a MACS separator (Miltenyi Biotec) and MACS columns (Miltenyi Biotec) was carried out. To enrich the purity of the separated fraction, an additional separation was performed over a second column and cells were stained with Fluorogold (Life Technologies) to label dead cells. Second, FACS sorting was performed, retrieving 10,215 cells.
+ Open protocol
+ Expand
8

Expansion of iNKT Cells from PBMC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monocyte-derived dendritic cells (DC) were generated as previously reported[22 (link)]. Briefly, peripheral blood mononuclear cells (PBMC) were prepared using Ficoll-Plaque density gradient centrifugation protocol. Monocytes were isolated via plastic adherence, and cultured in TCM containing IL-4 (100 ng/ml) and GM-CSF (200 IU/ml) for 5 days. After irradiation (5000 cGy), DC were cryopreserved until further use. Dendritic cells from a single donor were used to expand iNK T cells from up to 4 – 5 allogeneic donors. The iNK T cells were first enriched from 2×108 to 1×109 PBMC prepared from the entire leukopak using anti-iNKT-MicroBeads and Magnetic Activated Cell Sorting (MACS) separation according to the manufacturer’s instructions (Miltenyi Biotech). Subsequently, they wereco-cultured with 2×105 DC per well in 1–3 wells of 24 well tissue culture plate in TCM in the presence of αGalCer (100 nM) and IL-2 (200 IU/ml) for 10–14 days. Growth factor and TCM was replenished in every 2–3 days, but αGalCer was not.
+ Open protocol
+ Expand
9

Purification and Sequencing of iNKT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human iNKT cells were initially purified from PBMCs or thymi using anti-iNKT MicroBeads (clone 6B11, Miltenyi Biotec, Auburn, CA). Subsequently, the cells were stained with anti-Vα24 (clone C15) and anti-Vβ11 mAbs. The double positive population was sorted with a FACSAria (BD Biosciences, Mississauga, Canada). The purity of the sorted cells was consistently >95%. TCRβ sequencing was performed at Adaptive Biotech using the ImmunoSEQ platform (Seattle, WA). This method was used to capture the frequencies of individual TCRs in biologic samples with accurate reproducibility and a sensitivity of 1/100,000 T cells (26 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!